文献速递心力衰竭与心肌病

心力衰竭中铁缺乏的负担:治疗策略

The Burden of Iron Deficiency in Heart Failure: Therapeutic Approach.
PubMed 文献 · J Am Coll Cardiol · 2018-01-01

综述指出,稳定型慢性心衰患者中铁缺乏的检出率超过30%至50%,且会恶化预后;进行性心衰的病理机制可能与心肌铁缺乏相互交织。静脉补铁可能是安全有效的干预,或可减少心衰住院,文中提出了一套实用、综合、面向临床的铁补充算法。

要点

  • 稳定型慢性心衰患者中铁缺乏的检出率超过30%至50%,且与预后恶化相关。
  • 静脉补铁可能是安全有效的干预手段,可能减少心衰住院。
  • 对经过仔细筛选的患者,铁缺乏是缓解症状的新靶点,需按临床算法及时补铁。

核心结论

  • 铁缺乏在稳定型慢性心衰患者中普遍存在并恶化预后,是经过仔细筛选的患者缓解症状的新靶点;静脉补铁可能安全有效并可能减少心衰住院。

研究设计与样本

  • 综述,讨论心衰中铁治疗的证据与知识空白,并提出面向临床的补铁算法。

主要发现

  • 稳定型慢性心衰患者中铁缺乏的检出率超过30%至50%。
  • 进行性心衰的病理生理机制可能与心肌铁缺乏相互交织、互为因果。

关键数值与推荐

  • 文中提出针对不同临床场景及时充分补铁的实用、综合、面向临床的算法。

临床怎么用

  • 对经过仔细筛选的稳定型慢性心衰患者,可考虑静脉补铁以缓解症状,并关注干预前的决策与策略弊端。

局限性

  • 文中讨论了干预前必须进行的决策以及该策略的弊端,并指出铁治疗相关证据仍存在知识空白。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Heart failure (HF) is highlighted by its burdening symptom-limited exercise capacity and recurrent hospitalizations. Despite substantial advances regarding disease-modifying drugs in HF with reduced ejection fraction, additional therapeutic strategies to improve quality of life are invaluable. Currently, iron deficiency (ID) is overwhelmingly recognized in over 30% to 50% of patients with stable chronic HF, which worsens prognosis. The established pathophysiological mechanisms of progressive HF may be intertwined with increasing myocardial iron scarcity, wherein one begets the other. Most importantly, ID constitutes a novel target for symptom relief in carefully selected patients. In this regard, intravenous iron may be a safe and efficacious intervention, potentially reducing HF hospitalizations. We discuss the evidence and gaps in knowledge concerning iron therapy in HF and propose a practical, comprehensive, clinically oriented algorithm for timely adequate iron replenishment in different clinical scenarios. Finally, we further debate imperative decision-making before intervention and the drawbacks of such a strategy.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Rocha BML, Cunha GJL, Menezes Falcão LF, et al. The Burden of Iron Deficiency in Heart Failure: Therapeutic Approach. J Am Coll Cardiol. 2018. PMID: 29447741. doi:10.1016/j.jacc.2017.12.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。